Search results for "Cardiac"

showing 10 items of 1495 documents

Left ventricular diastolic filling alterations in subjects with mitral valve prolapse: A Doppler echocardiographic study

1993

To assess left ventricular diastolic filling in mitral valve prolapse (MVP), we studied 22 patients with idiopathic MVP and 22 healthy controls matched for sex, age, body surface area and heart rate. A two-dimensional, M-mode and Doppler echocardiographic examination was performed to exclude any cardiac abnormalities. The two groups had similar diastolic and systolic left ventricular volumes, left ventricle mass and ejection fraction. Doppler measurements of mitral inflow were: E and A areas (the components of the total flow velocity-time integral in the early passive period of ventricular filling, E; and the late active period of atrial emptying, A), the peak E and A velocities (cm.s-1), a…

AdultMalemedicine.medical_specialtyCardiac outputSettore MED/09 - Medicina InternaAdolescentHeart VentriclesDiastoleVentricular Function LeftDiastoleInternal medicineMitral valvemedicineHumansVentricular FunctionMitral valve prolapseCardiac OutputBody surface areaMitral Valve ProlapseEjection fractionE/A ratiobusiness.industrymedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareEchocardiography Dopplermedicine.anatomical_structureVentricleCase-Control StudiesDiastolic dysfunction echocardiographic findings transmitral flow velocity left ventricular filling.cardiovascular systemCardiologyFemaleCardiology and Cardiovascular MedicinebusinessBlood Flow Velocity
researchProduct

Lymphocyte beta-adrenergic receptors in young subjects with peripheral or central obesity: relationship with central haemodynamics and left ventricul…

1994

This study was designed to evaluate total (t) and surface (s) β-adrenergic receptor (BAR) density and their relationship with central haemodynamics and left ventricular function in young subjects with central or peripheral obesity. A total of 31 obese subjects (BMI ≥30.5 kg. m−2 for males and >27.3 kg. m−2 for females) aged less than 40 years and without other risk factors for cardiovascular diseases (smoking, hypertension, diabetes and lipid abnormalities) were studied. Nine had peripheral obesity and 22 central obesity according to WHR values; there were 20 lean controls (BMI <25 kg. m−2 for males and <24.7 kg. m−2 for females). Casual (c) and 24 h ambulatory mean blood pressures (MBP-24 …

AdultMalemedicine.medical_specialtyCardiac outputSettore MED/09 - Medicina InternaMegalencephalic leukoencephalopathy with subcortical cystsEpinephrineDiastoleHemodynamicsBlood volumeVentricular Function LeftBody Mass IndexNorepinephrineRisk FactorsInternal medicineDiabetes mellitusReceptors Adrenergic betamedicineHumansInsulinLymphocytesObesitySystoleRadionuclide ImagingEjection fractionbusiness.industryHemodynamicsHeartmedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareEndocrinologyCardiovascular DiseasesEchocardiographyBody ConstitutionRegression AnalysisPeripheral obesity Central Obesity Lymphocyte beta adrenergic receptors left ventricular functionFemaleCardiology and Cardiovascular MedicinebusinessEuropean Heart Journal
researchProduct

Haemodynamic effects of a single intravenous dose of lorcainide in patients with heart disease

1980

The cardiovascular effects of a single i.v. dose (2 mg/kg over 5 min) of lorcainide were studied in 14 patients with heart disease. In the haemodynamic part of the study (6 patients), the aortic and pulmonary systolic, diastolic and mean pressures, left ventricular systolic and end-diastolic pressures, cardiac output and the rate of rise of left ventricular pressure were measured before and for 30 min after administration of the drug. Lorcainide produced a slight and short-lasting decrease in the aortic and pulmonary systolic pressures, and all other pressure values remained unchanged. The cardiac output and systemic vascular resistance were not altered by lorcainide. It consistently depres…

AdultMalemedicine.medical_specialtyCardiac outputTime FactorsHeart DiseasesHeart diseaseBenzeneacetamidesDiastoleHemodynamicsBlood PressureLorcainidePiperidinesInternal medicinemedicineHumansPharmacology (medical)Cardiac OutputAgedPharmacologyEjection fractionbusiness.industryHeartGeneral MedicineMiddle Agedmedicine.diseaseMyocardial Contractionmedicine.anatomical_structureAnesthesiaVascular resistanceVentricular pressureCardiologyFemaleVascular ResistancebusinessAnti-Arrhythmia Agentsmedicine.drugEuropean Journal of Clinical Pharmacology
researchProduct

Identification of acute myocardial infarction in elderly patients using optimized highly sensitive troponin I thresholds

2019

Purpose: Established diagnostic thresholds for high-sensitivity cardiac troponins (hs-cTn) might not apply for elderly patients as they are elevated irrespective of the presence of an acute myocardial infarction (AMI). Aim of the present study was to investigate hs-cTnI in elderly patients with suspected AMI and to calculate optimized diagnostic cutoffs. Material and methods: Data from a prospective multi-centre study and from a second independent prospective single-centre cohort study were analysed. A number of 2903 patients were eligible for further analysis. Patients &gt; 70 years were classified as elderly. hs-cTnI was measured upon admission. Results: Around 34.7% of 2903 patients were…

AdultMalemedicine.medical_specialtyCardiac troponinHealth Toxicology and Mutagenesishealth care facilities manpower and servicesClinical BiochemistryMyocardial InfarctionHyperlipidemias030204 cardiovascular system & hematologyBiochemistrySensitivity and Specificity03 medical and health sciences0302 clinical medicineRisk FactorsInternal medicineTroponin ImedicineHumansMyocardial infarctionProspective Studiescardiovascular diseaseshealth care economics and organizationsAgedAged 80 and overbiologybusiness.industrySmokingTroponin IMiddle Agedmedicine.diseaseTroponinhumanitiesHighly sensitive030220 oncology & carcinogenesisHypertensionCardiologybiology.proteinFemalebusinessBiomarkers
researchProduct

Long-Term Enoximone Therapy in Unstable Chronic Heart Failure

1989

Long-term safety and efficacy of oral enoximone were evaluated in 32 patients with unstable chronic heart failure despite digitalis, diuretics, and vasodilator therapy. Oral enoximone, 75-150 mg t.i.d. was given for an average of 32 weeks. At baseline, 21 patients were in NYHA functional class IV, 10 patients in class III, and 1 patient in class II. Within 12 weeks, 14 of 20 patients surviving for more than 26 weeks had improved by at least one functional class. Hemodynamic data showed an 18% increase of cardiac index and a 34% decrease of diastolic pulmonary artery pressure. Echocardiographic recordings revealed an increase of fractional shortening from 13.9 +/- 7 to 15.6 +/- 5% after 12 w…

AdultMalemedicine.medical_specialtyCardiotonic AgentsHeart diseaseCardiac indexDiastoleSudden deathElectrocardiographyInternal medicinemedicine.arterymedicineHumansEnoximoneEnoximoneSurvival rateAgedAged 80 and overHeart FailurePharmacologybusiness.industryHemodynamicsImidazolesMiddle Agedmedicine.diseaseSurgeryHeart failureChronic DiseasePulmonary arteryCardiologyFemalebusinessCardiology and Cardiovascular Medicinemedicine.drugJournal of Cardiovascular Pharmacology
researchProduct

A functional study of the esophagus in patients with non-cardiac chest pain and dysphagia.

2015

Background/Aims: Nutcracker esophagus and non-specific motility disorders are the main causes of non-cardiac chest pain (NCCP), with gastroesophageal reflux in 60% of cases. Achalasia and diffuse esophageal spasm are the most frequent anomalies described in patients with dysphagia. The goal of this study was to evaluate the occurrence of esophageal body and lower esophageal sphincter motor abnormalities in patients with dysphagia, NCCP, or both. Materials and Methods: This study is a retrospective analysis of 716 patients with NCCP and/or dysphagia tested between January 1994 and December 2010. 1023 functional studies were performed, 707 of which were esophageal manometries, 225 esophageal …

AdultMalemedicine.medical_specialtyChest PainManometryAchalasiaChest painEsophaguGastroenterologyEsophageal Sphincter LowerEsophagusRetrospective StudieInternal medicineotorhinolaryngologic diseasesmedicineHumansIn patientEsophagusDeglutition DisorderNon-cardiac chest painAgedRetrospective StudiesSettore MED/12 - Gastroenterologiabusiness.industryMedicine (all)Esophageal dyskinesiaDysphagia; Esophageal dyskinesia; Gastroesophageal reflux; Non-cardiac chest pain; Adult; Aged; Chest Pain; Deglutition Disorders; Esophageal Achalasia; Esophageal Sphincter Lower; Esophageal Sphincter Upper; Esophagus; Female; Gastroesophageal Reflux; Humans; Hydrogen-Ion Concentration; Male; Manometry; Middle Aged; Retrospective Studies; Gastroenterology; Medicine (all)RefluxGastroenterologyNutcracker esophagusDysphagiaHydrogen-Ion ConcentrationMiddle Agedmedicine.diseaseEsophageal Sphincter UpperDysphagiaSurgeryEsophageal AchalasiaSettore MED/18 - Chirurgia Generalemedicine.anatomical_structureGastroesophageal RefluxEsophageal spasmFemalemedicine.symptombusinessDeglutition DisordersHumanThe Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology
researchProduct

Clinical characteristics and determinants of the phenotype in TMEM43 arrhythmogenic right ventricular cardiomyopathy type 5.

2020

Arrhythmogenic right ventricular cardiomyopathy type V (ARVC-5) is the most aggressive heterozygous form of ARVC. It is predominantly caused by a fully penetrant mutation (p.S358L) in the nondesmosomal gene TMEM43-endemic to Newfoundland, Canada. To date, all familial cases reported worldwide share a common ancestral haplotype. It is unknown whether the p.S358L mutation by itself causes ARVC-5 or whether the disease is influenced by genetic or environmental factors. The purpose of this study was to examine the phenotype, clinical course, and the impact of exercise on patients with p.S358L ARVC-5 without the Newfoundland genetic background. We studied 62 affected individuals and 73 noncarrie…

AdultMalemedicine.medical_specialtyDNA Mutational AnalysisMutation MissenseDisease030204 cardiovascular system & hematologyVentricular Function LeftRight ventricular cardiomyopathySudden cardiac deathElectrocardiography03 medical and health sciences0302 clinical medicinePhysiology (medical)Internal medicinemedicineGeneticsHumans030212 general & internal medicineExerciseArrhythmogenic Right Ventricular DysplasiaEjection fractionTMEM43business.industryIncidence (epidemiology)HaplotypeMembrane ProteinsStroke VolumeDNAmedicine.diseasePhenotypePedigree3. Good healthPhenotypeMutation (genetic algorithm)CardiologyFemaleCardiology and Cardiovascular MedicinebusinessArrhythmogenic right ventricular cardiomyopathyArrhythmia
researchProduct

PQ Interval in Patients With Fabry Disease

2010

Fabry disease (FD) is an X-chromosomal inherited lysosomal storage disease resulting in intracellular storage of globotriaosylceramide. Cardiac involvement is most frequently manifested as left ventricular hypertrophy. However, patients with FD may also have from various conduction abnormalities particularly affecting atrioventricular (AV) conduction. The present study was designed to analyze primarily AV conduction abnormalities on baseline electrocardiograms of patients with FD and to investigate the correlation with echocardiographic findings. Electrocardiograms at rest of 207 patients with FD were compared to echocardiograms. PQ-interval shortening and first-degree AV block could be fou…

AdultMalemedicine.medical_specialtyDiastoleLeft ventricular hypertrophyMuscle hypertrophyCohort StudiesElectrocardiographyYoung AdultInternal medicinePrevalencemedicineHumanscardiovascular diseasesPR intervalAtrioventricular Blockmedicine.diagnostic_testVascular diseasebusiness.industryArrhythmias CardiacMiddle Agedmedicine.diseaseFabry diseaseEchocardiography DopplerElectrocardiographic FindingCardiologyFabry DiseaseFemaleHypertrophy Left VentricularCardiology and Cardiovascular MedicinebusinessElectrocardiographyThe American Journal of Cardiology
researchProduct

Quantification of mitral valve stenosis by three-dimensional transesophageal echocardiography

1996

The aim of this study was the evaluation of the diagnostic potentials of transesophageal 3D- echocardiography in the determination of mitral valve stenosis. 54 patients were investigated by transthoracic and multiplane transesophageal echocardiography. In 41 patients cardiac catheterization was performed. 3D- echocardiographic data acquisition was performed by automatic transducer rotation at 2 degree increments over a span of 180 degrees. The transesophageal probe was linked to an ultrasound unit and to a 3D- workstation capable of ECG- and respiration gated data acquisition, postprocessing and 2D/3D image reconstruction. The mitral valve was visualized in sequential cross-sectional planes…

AdultMalemedicine.medical_specialtyDuplex ultrasonographyImage qualitymedicine.medical_treatmentDoppler echocardiographyMitral valve stenosisMitral valveImage Processing Computer-AssistedmedicineHumansMitral Valve StenosisRadiology Nuclear Medicine and imagingCardiac imagingAgedCardiac catheterizationObserver Variationmedicine.diagnostic_testbusiness.industryUltrasoundMiddle Agedmedicine.diseaseEchocardiography Dopplermedicine.anatomical_structureFemaleRadiologyCardiology and Cardiovascular MedicinebusinessEchocardiography TransesophagealThe International Journal of Cardiac Imaging
researchProduct

Mechanics of pericardial effusion: A simulation study

2015

Pericardial effusion is a pathological accumulation of fluid within pericardial cavity, which may compress heart chambers with hemodynamic impairment. We sought to determine the mechanics underlying the physiology of the hemodynamic impairment due to pericardial effusion using patient-specific computational modeling. Computational models of left ventricle and right ventricle were based on magnetic resonance images obtained from patients with pericardial effusion and controls. Myocardial material parameters were adjusted, so that volumes of ventricular chambers and pericardial effusion agreed with magnetic resonance imaging data. End-diastolic and end-systolic pressure–volume relationships …

AdultMalemedicine.medical_specialtyFinite Element AnalysisDiastolePericardial effusionPericardial effusionYoung AdultSettore ING-IND/14 - Progettazione Meccanica E Costruzione Di MacchineFinite Element AnalysiInternal medicineCardiac tamponademedicineSettore ING-IND/12 - Misure Meccaniche E TermichePericardiumHumansInterventricular septumcomputer modelingAgedAged 80 and overbusiness.industryMechanical EngineeringPericardial cavityModels CardiovascularSettore ING-IND/34 - Bioingegneria IndustrialeGeneral MedicineStroke volumeMechanicsmedicine.diseaseCardiac Tamponademedicine.anatomical_structureVentricleCardiologyFemaleRadiologybusinessHuman
researchProduct